Biomaterial Database

Combined therapy of neuroblastoma. 1968

C W Van Way, and R B Carlisle, and S E Stephenson

UI	MeSH Term	Description	Entries
D007223	Infant	A child between 1 and 23 months of age.	Infants
D007231	Infant, Newborn	An infant during the first 28 days after birth.	Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D009362	Neoplasm Metastasis	The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.	Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009447	Neuroblastoma	A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)	Neuroblastomas
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002675	Child, Preschool	A child between the ages of 2 and 5.	Children, Preschool,Preschool Child,Preschool Children
D003520	Cyclophosphamide	Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.	(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260	Female		Females

Related Publications

C W Van Way, and R B Carlisle, and S E Stephenson

Olfactory neuroblastoma: results of combined therapy.

June 1994, Indian journal of cancer,

C W Van Way, and R B Carlisle, and S E Stephenson

[Clinical efficacy of combined therapy in children with stage 4 neuroblastoma].

July 2022, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,

C W Van Way, and R B Carlisle, and S E Stephenson

Combined treatment with cisplatin and radiation therapy for mouse Cl 300 neuroblastoma.

February 1985, Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood,

C W Van Way, and R B Carlisle, and S E Stephenson

Radiation therapy of neuroblastoma.

January 1957, Radiology,

C W Van Way, and R B Carlisle, and S E Stephenson

Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma.

February 2017, Nanomedicine : nanotechnology, biology, and medicine,

C W Van Way, and R B Carlisle, and S E Stephenson

Neuroblastoma: biology and therapy.

December 1997, Oncology (Williston Park, N.Y.),

C W Van Way, and R B Carlisle, and S E Stephenson

Advances in neuroblastoma therapy.

February 2019, Current opinion in pediatrics,